142 related articles for article (PubMed ID: 12741071)
1. [ALLHAT: Old Hat Hits All? On selection of the optimal antihypertensive drug].
Slany J
Wien Klin Wochenschr; 2003 Mar; 115(5-6):149-51. PubMed ID: 12741071
[No Abstract] [Full Text] [Related]
2. [Established blood pressure drug wins out in a comparative study. In hypertension, a diuretic first!].
Wepner U
MMW Fortschr Med; 2003 Jan; 145(1-2):10-2. PubMed ID: 12638431
[No Abstract] [Full Text] [Related]
3. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results From the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
Dewland TA; Soliman EZ; Yamal JM; Davis BR; Alonso A; Albert CM; Simpson LM; Haywood LJ; Marcus GM
Circ Arrhythm Electrophysiol; 2017 Dec; 10(12):. PubMed ID: 29212812
[TBL] [Abstract][Full Text] [Related]
5. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
[TBL] [Abstract][Full Text] [Related]
6. The ALLHAT Trial. Diuretics are still the preferred initial drugs for high blood pressure.
Vidt DG
Cleve Clin J Med; 2003 Mar; 70(3):263-9. PubMed ID: 12678218
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Wright JT; Harris-Haywood S; Pressel S; Barzilay J; Baimbridge C; Bareis CJ; Basile JN; Black HR; Dart R; Gupta AK; Hamilton BP; Einhorn PT; Haywood LJ; Jafri SZ; Louis GT; Whelton PK; Scott CL; Simmons DL; Stanford C; Davis BR
Arch Intern Med; 2008 Jan; 168(2):207-17. PubMed ID: 18227370
[TBL] [Abstract][Full Text] [Related]
8. The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Juraschek SP; Simpson LM; Davis BR; Shmerling RH; Beach JL; Ishak A; Mukamal KJ
J Hypertens; 2020 May; 38(5):954-960. PubMed ID: 31977576
[TBL] [Abstract][Full Text] [Related]
9. [What are the sequelae of the ALLHAT Study?].
Vetter W;
Dtsch Med Wochenschr; 2003 Mar; 128(13):687. PubMed ID: 12698959
[No Abstract] [Full Text] [Related]
10. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS).
Grimm RH; Grandits GA; Prineas RJ; McDonald RH; Lewis CE; Flack JM; Yunis C; Svendsen K; Liebson PR; Elmer PJ
Hypertension; 1997 Jan; 29(1 Pt 1):8-14. PubMed ID: 9039073
[TBL] [Abstract][Full Text] [Related]
11. [The new (old) knowledge in primary prevention of stroke. It depends on lowering of blood pressure].
Düsing R
MMW Fortschr Med; 2003; 145 Suppl 1():6. PubMed ID: 12958795
[No Abstract] [Full Text] [Related]
12. [ALLHAT trial--antithesis to the overuse of vasodilating antihypertensive drugs].
Kuwajima I
Nihon Rinsho; 2004 Mar; 62 Suppl 3():648-53. PubMed ID: 15171450
[No Abstract] [Full Text] [Related]
13. Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Cushman WC; Ford CE; Einhorn PT; Wright JT; Preston RA; Davis BR; Basile JN; Whelton PK; Weiss RJ; Bastien A; Courtney DL; Hamilton BP; Kirchner K; Louis GT; Retta TM; Vidt DG;
J Clin Hypertens (Greenwich); 2008 Oct; 10(10):751-60. PubMed ID: 19090876
[TBL] [Abstract][Full Text] [Related]
14. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Black HR; Davis B; Barzilay J; Nwachuku C; Baimbridge C; Marginean H; Wright JT; Basile J; Wong ND; Whelton P; Dart RA; Thadani U;
Diabetes Care; 2008 Feb; 31(2):353-60. PubMed ID: 18000186
[TBL] [Abstract][Full Text] [Related]
15. [Are all antihypertensive agents equal? Cardiovascular events in hypertensive patients randomized to treatment with doxazosin or chlorthalidone. The ALLHAT study].
Schillaci G; Verdecchia P
Ital Heart J Suppl; 2000 Sep; 1(9):1215-7. PubMed ID: 11140297
[No Abstract] [Full Text] [Related]
16. Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT.
Yamal JM; Oparil S; Davis BR; Alderman MH; Calhoun DA; Cushman WC; Fendley HF; Franklin SS; Habib GB; Pressel SL; Probstfield JL; Sastrasinh S;
J Am Soc Hypertens; 2014 Nov; 8(11):808-19. PubMed ID: 25455006
[TBL] [Abstract][Full Text] [Related]
17. Alpha-blockers and congestive heart failure: early termination of an arm of the ALLHAT trial.
Vidt DG
Cleve Clin J Med; 2000 Jun; 67(6):429-33. PubMed ID: 10860225
[TBL] [Abstract][Full Text] [Related]
18. Results of the ALLHAT trial: is the debate about initial antihypertensive drug therapy over?
Moser M
J Clin Hypertens (Greenwich); 2003; 5(1):5-8. PubMed ID: 12556646
[No Abstract] [Full Text] [Related]
19. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763
[TBL] [Abstract][Full Text] [Related]
20. The ALLHAT report: a case of information and misinformation.
Weber MA
J Clin Hypertens (Greenwich); 2003; 5(1):9-13. PubMed ID: 12556647
[No Abstract] [Full Text] [Related]
[Next] [New Search]
